We have previously described a system that displays real-time estimates of effect-site sevoflurane concentrations. Estimates of effect-site levels should be similar to minimum alveolar concentration (MAC) values, which are determined after allowing time for equilibrium. This study aimed to determine estimated effect-site sevoflurane concentrations at awakening from routine anaesthesia and to compare this with published estimates of MACawake. If these values were similar, this would validate our approach to the calculation of effect-site concentration. Sixty-five patients undergoing a variety of surgical procedures were observed. Prior to disconnection from the breathing circuit, forward estimates of effect-site sevoflurane were recorded. Patients were observed in the postanaesthesia care unit and the time at which they responded to command was recorded. Age-adjusted effect-site sevoflurane at the time of awakening was determined. Correlation with patient, surgical and anaesthetic factors including age, gender, ASA status and intraoperative opioid usage were explored. Mean age-adjusted calculated effect-site concentration at awakening was 0.59 (SD 0.27) vol%. This value is within the range of values determined for MAC-awake of sevoflurane. There was no correlation with any of the demographic or anaesthetic factors, but patients undergoing major surgery woke at a significantly lower mean sevoflurane level. These results support the use of effect-site sevoflurane concentration to guide administration of anaesthesia.
We have previously described a system which provides real-time estimates and forward predictions of effect-site concentrations of inhalational anaesthetics 1 . The effect-site would intuitively appear to be a logical 'target' for control of any drug. However to demonstrate the clinical utility of real-time estimates of effect-sites it would be useful to relate these effectsite values to known clinical measures of anaesthetic effect. Various measures of anaesthetic potency based on the concept of minimum alveolar concentration (MAC) 2 have been described. The MAC for any response is the alveolar concentration at which 50% of subjects show that response. Since MAC is determined after maintaining a given alveolar concentration for 10 to 20 minutes to allow equilibrium between the alveolar and brain (or effect-site) concentrations, the 'MAC' for a given response should be similar to the effect-site concentration required to produce that response in 50% of subjects. If the calculation of effect-site concentration is valid then these effect-site concentrations should be similar to those determined for the MAC for that response but without the need to wait for equilibrium to occur. in a number of studies at 0.58 to 0.67 vol% [3] [4] [5] . The primary aim of this study was to determine the at wake-up in patients undergoing a wide range of surgery and to compare this value to published estimates of MAC-awake. We also wished to explore site concentration at wake-up and other patient, anaesthetic and surgical parameters.
METHODS
This study was approved by the Canterbury Regional Ethics Committee. As the study collected and collated data routinely collected in the perioperative period, and did not involve intervention or additional data collection, individual patient consent was not required by the Committee.
The prediction system
Our model-based predictive display for volatile vaporizer setting from the anaesthetic machine (Datex ADU) and monitor (Datex A/S3) every ten seconds and uses this to model the progress of the anaesthetic in a nine compartment model. We have previously shown that, despite a number of potential limitations, systems predict effect-site propofol levels 6 . Calculation of effect-site concentration (Ceff) is dependent only on blood (or central compartment) concentration, estimated by ET values, and on the value chosen for compartments (ke0). We use a value for t1/2 ke0 of 3.2 minutes 7-9 to provide an estimate of Ceff which is also updated every ten seconds. The predicted concentrations in the lung and brain compartments of the model are then aligned to the current ET and Ceff respectively and displayed numerically and graphically setting the user can rapidly see the effect of different input patterns and choose that which best suits the clinical needs. We have previously demonstrated that this display allows anaesthetists to make step changes the display is unavailable 10 .
Subjects
Over an eight-week period (November 2004 to January 2005) 65 patients in whom surgery was expected to last more than 30 minutes were observed. Selection was based on the availability of the observer (MS) and of suitable subjects in one of the four operating theatres in which our predictive/display system is installed. Subjects were selected on the without the use of nitrous oxide, and were divided into three groups based on the invasiveness of the as peripheral orthopaedic or laparoscopic procedures;
Approximately equal numbers of patients were observed in each group to ensure a wide distribution of patient types. The actual conduct of the anaesthetic was entirely at the discretion of the anaesthetist in charge of the case.
At the time of disconnection of the patient from the anaesthetic breathing system the predicted effect-site concentrations for the following 20 minutes were recorded. The observer then followed the patient into the post-anaesthesia care unit (PACU) and as eye-opening and response to command. Additional information including patient demographics (age, gender, weight), ASA status, duration and timing of the surgery and fentanyl, morphine and midazolam dosing were obtained from the anaesthetic record. of wake-up was taken as that predicted for the point in time at which the patient awoke. This value was then corrected for age using the relationship between MAC values and age described by Mapleson 11 . Effect-site fentanyl levels at the time of awakening were calculated by entering fentanyl doses and times into an Excel spreadsheet utilizing Scott's parameters 12 . FIGURE 1: An example of the effect-site display and prediction system. The graphs on the left are in two parts: the shaded area shows the sevoflurane concentration over time while the darker line is the calculated effect-site concentrations. The dashed lines extending to the right represent the predicted endtidal and effect-site concentrations. Data are shown numerically on the right. The top two lines show the vaporizer dial setting and total fresh gas flow (from the Datex ADU) and the measured inspired and expired sevoflurane levels (Datex A/S3). Below this are the current effect-site concentration ("Calc Brain") and the forward predictions. In this example the vaporizer has been turned off following a brief period with a high dial setting.
Statistics
Data from all groups were pooled and tested for normal distribution using a Kolmogorov-Smirnov test. Mean and standard deviation or median and interquartile range (IQR) were determined as appropriate. Results from the three groups were compared using a one-way ANOVA with Tukey's HSD post test or a Kruskal-Wallis test with Dunn's Multiple Comparison Test as a post test. Correlation patient and anaesthetic factors was explored using appropriate. In all cases a P value <0.05 was taken Diego, California, U.S.A.).
RESULTS
Data was collected and analysed for 65 cases. The mean duration of the procedures was 101 minutes (SD 54 minutes). The average age of the patients was 54 17 . The median ASA score was 2.0 (IQR 1-3). The median total dose of fentanyl was 95 μg (IQR 100-200 μg) and of morphine 5 mg (0-10 mg).
concentration varied between 0.12 vol% and 1.2 vol% with a mean of 0.58 vol% (SD 0.27 vol%) while the median estimated fentanyl effect-site level was 0.29 ng/ml (IQR 0.22-0.53 ng/ml). The individual data points are illustrated in Figure 2 . Table 1 summarizes the data and the statistical analysis for the pooled data and for each of the surgical age were all normally distributed; other parameters status (P=0.015) and duration of surgery (P=0.03).
ASA status (P=0.02), duration (P<0.0001), total Effect site sevo at wake-up (%) fentanyl dose (P=0.019), fentanyl levels (P=0.0006) centration (P=0.0018). There was no effect of gender on wake-up levels (P ferences between groups for each parameter are indicated on Table 1 .
DISCUSSION
woke at a mean age-adjusted estimated effect-site (95% CI 0.52-0.66 vol%). This is within the range (0.58-0.67 vol%) determined in several studies of [3] [4] [5] . This observation supports the hypothesis that real-time effect-site estimates are similar to MAC values and supports the use of effect-site estimates as a guide to the delivery of volatile anaesthetic agents although the variability in our results is much greater than seen in studies of MAC-awake. This variability may be due to inherent variability between patients or may be due to the multiple other factors affecting anaesthetic requirements during routine anaesthesia and surgery. Of interest all values were less than 1.2 vol% (0.6 MAC) with the 95th centile at 1.0 vol%.
The second observation is that subjects undergoing 95% CI 0.31-0.50 vol%) than subjects in the other two groups, both of which fall within the reported mediate surgery 0.63 vol%, 95% CI 0.57-0.80 vol%). This difference has not been reported in studies of MAC-awake. However, studies into MAC-awake tend to involve subjects undergoing less invasive surgery to allow the effects of various drugs to be studied in isolation. One implication of this result is that care should be taken when extrapolating various MAC values into groups and clinical settings where the conditions of the particular studies are not identical.
to be older, have a higher ASA score, receive more opioids and have a longer duration of anaesthesia than subjects in the other two groups. The only and duration of surgery. Modest opioid doses have a profound effect on the MAC values for various stimuli, such as skin incision or intubation 13, 14 . The effect on MAC-awake is much less profound. Morphine in doses of 10 mg 15 or 0.1 mg/kg 16 has been shown to have no effect. Fentanyl levels of 4 ng/ml have been shown to reduce MAC-awake while 2 ng/ml has no effect 5 . In the present study the maximum estimated fentanyl level at the time subjects was 0.28 ng/ml. Although the effect of combinations of opioids on MAC-awake has not been determined, it is unlikely that the total opioid levels were above the equivalent of 2 ng/ml of fentanyl and, additionally, awakening effect-site fentanyl levels were highest in the minor surgery group.
A number of other factors may also contribute to amongst subjects. These include the use of adjunctive drugs, major nerve blocks, environmental factors such as temperature and the effects of major surgery itself. Although the study was not designed to investigate these effects, they do deserve some comment.
Other drugs used included benzodiazepines both as premedication and preinduction. Intravenous midazolam was used in 19 of the 65 subjects. Overall and within each group there was no correlation between midazolam use or dose and wake-up levels, as shown in Table 1 . One subject in each group reat wake-up for these subjects were 0.42, 0.36 and been shown to be reduced by 20% in the presence of epidural blockade 17 , these data points are not of temperature on MAC is well known 18, 19 . Although there is limited human data available, the decrease in MAC for stimulation is around 5% per °C. This between the groups, but it may be that, in contrast to the effect of opioids, temperature has a greater effect on MAC-awake than on MAC stimulation. Of interest is the observation that gender did not affect the wake-up levels. This supports previous work on MAC-awake 20,21 , but contrasts with recent work suggesting that women wake faster than men following anaesthesia and are possibly less sensitive to the hypnotic effect of anaesthetic agents 22 .
MAC-awake and the concept of effect-site the duration of surgery. In this study there was a up when all groups are combined. However Figure  3 explores the relationship between duration and
Within each group there is no correlation between 716 R. R. KENNEDY, M. M. SAKOWSKA results suggest that duration alone is not a factor in the delayed wakeup and that the correlation in the pooled data is because the major cases, which woke at lower levels, lasted longer rather than a direct effect of duration. This is one of a number of observations from this study requiring further investigation. The effect of age on MAC-awake parallels the welldocumented effects of age on MAC of around 6% per decade 11, 20, 23 . Our data is adjusted for age using a standard approach. We did not demonstrate a correlation between age and awakening levels supporting the parallel effects of age on MAC and MAC-awake 20 . We also explored other parameters in our data set, such as use of midazolam, but were unable to demonstrate an effect of these parameters.
As illustrated by the factors discussed above, a weakness of this study is that the conduct of anaesthesia was not standardized beyond the use of results seen. However, we also see this lack of standardization as a potential strength of this study since, given the similarity between wake-up effectand intermediate surgery groups, these results may be applicable over a wide range of patients, types of surgery and other anaesthetic factors.
Until the 1990s, control of delivery of inhalational anaesthetic agents was based on the rate of delivery (vaporizer and fresh gas settings) to the breathing system. The widespread availability of agent analysis has allowed the use of end-tidal (ET) concentrations as the target. In combination with less soluble agents, this has allowed improved titration and control of levels of anaesthesia. However there is still a considerable delay between changes in ET concentration and effect-site concentration since the effect-site equilibrium half times (t1/2 ke0) for these agents are around three minutes which is longer than commonly accepted values for propofol (time to peak effect 1.6 minutes 24 ) or remifentanil (t1/2 ke0 of one minute) 25 .
Effect-site guided anaesthesia delivery should allow delivery of agents to be more closely matched to the changing needs of the patient at different stages of surgery. Studies with propofol have demonstrated that propofol effect-site concentrations are more closely related to clinical endpoints than plasma levels 24, 26 and that providing the anaesthetist with effect-site information improves the stability of effectsite concentrations 27, 29 . When combined with forward prediction 1 , the display of effect-site information allows the anaesthetist to adjust delivery based on both current and anticipated future demands 10, 29 .
Several studies have suggested that lower concentrations of an inhalational agent, usually in combination with increased opioid levels, are associated with improved short-term 30,31 and possibly longterm 32 recovery characteristics. The optimum combinations determined in these studies are end-tidal levels in the range 40-80% MAC. At these levels the decrement time to MAC-awake is short and small alterations in the balance between effect-site concentration and level of stimulation may produce unwanted clinical effects, such as movement. Effectsite guided delivery may make maintaining appropriate levels more straightforward 29 than the use of end-tidal levels alone. In addition, our predictive display gives a real-time illustration of inhalation decrement times (Figure 1 ). These tools may assist the anaesthetist to optimize levels of the various components of anaesthesia for various stages of a procedure rather than relying on end-tidal values.
This study has shown that, in a wide variety of anaesthesia at age-adjusted estimated effect-site levels within the range previously reported for MACawake. This data supports the use of estimated effectsite concentrations as a guide to anaesthesia delivery. Subjects undergoing major surgery woke at sigtions than those having minor or intermediate surgery.
Although many reasons for this difference can be postulated, the reasons for this difference are not FIGURE 3: Plot of age-adjusted effect-site sevoflurane levels at wake-up against duration for the major surgery group. Also shown data for groups 1 and 2 (---). The slopes of these lines are not significantly different from zero, implying no correlation between duration and wake-up sevoflurane effect-site levels. 
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